Synaptogenix, Inc has secured licensing agreements with both Icahn School of Medicine at Mount Sinai and Stanford University.
2 reports, 2 independent
Updated Oct 5
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Synaptogenix, Inc has secured licensing agreements with both Icahn School of Medicine at Mount Sinai and Stanford University.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Analyst downgraded Synaptogenix stock to sell rating.1 source
Synaptogenix signs licensing deals with Mount Sinai and Stanford University.1 source
Keep exploring
The entities involved
-
Icahn School of Medicine at Mount Sinai
medical school
-
Stanford University
private research university in Stanford, California, USA